Several previous authors noticed the production of a contralateral ptosis in cases where only one eye was being treated. This may be due either to systemic absorption of guanethidine or to a readjustment of sympathetic activity (Sneddon & Turner 1966) . One of our patients, a 42-year-old woman, had radioactive iodine treatment for her thyrotoxicosis in 1965 and a year later developed a left-sided proptosis with lid retraction and lid lag. She also had a mild congenital right ptosis. After treatment for two months with 10% guanethidine twice daily to the left eye, there was improvement in the position of the left upper lid but the right ptosis became more marked.
Miotic pupils were produced in all patients using these drops, but none complained of visual symptoms as a result of this.
A repeated finding in this series was that, although there is often a good response to treatment within a week or ten days, with continued therapy the improvement often proceeds further for some months.
Conjunctival vascular dilatation has been a problem in some cases; it was so marked in 3 of the 19 patients that the guanethidine had to be discontinued; in other cases reduction of dosage resulted in relief of symptoms. This vascular dilatation has also been a problem with bethanidine drops, which have been given a trial more recently. Bethanidine, which is pharmacologically similar to guanethidine, appears to be of equal efficiency in the treatment of dysthyroid lid retraction. Punctate corneal erosions have been described as a toxic effect of local guanethidine therapy, but were not noted in this series. It has recently been claimed that total removal or destruction of the thyroid gland is beneficial in cases of dysthyroid exophthalmos (Catz & Perzik 1965 , Bauer & Catz 1966 . The finding by some workers (McKenzie 1961 , Noguchi et al. 1964 , Pinchera et al. 1965 ) that significant titres of long-acting thyroid stimulator (LATS) are more commonly found in the serum of thyrotoxic patients with eye signs than in those without has led to the conjecture that LATS may have a causal role in the development of this complication. This situation, together with the finding that LATS is a thyroid specific antibody (Kriss et al. 1964 , Dorrington et al. 1966 , provided some rationale for the hypothesis that removal of all thyroid tissue from patients with severe dysthyroid exophthalmos might lead to a reduction in LATS levels and a concomitant improvement in the eye signs.
In March 1966 a working party of the Medical Research Council decided that the claims made for the beneficial effects of thyroid ablation were of sufficient importance to justify a controlled trial of this treatment. A parallel study was also to be made on the effect of thyroid ablation on the level of LATS in serum.
Outlinie of the MRC Tr-ial Patients with dysthyroid exophthalmos were randomly allocated to an ablation group and to a control group, the sole restriction on therapy being that thyroid ablation was not employed in the control group. Either surgical or radioiodine ablation was permitted, the latter being used in the patients described here. A detailed schedule for radioiodine therapy was issued, the main features being: (1) Only patients with eye signs of less than six months duration were included. (2) In order to minimize the total body radiation dose radioiodine ablation was carried out in a piecemeal fashion with an initial dose of up to 15 mc 1311 to control thyrotoxicosis and further similar doses of 1311 at two-month intervals thereafter until the 24-hour thyroid uptake was less than 3000O of the dose. Ablation doses of up to 100 mc 1311 were then given at six-monthly intervals until a five-day uptake of less than 0 2 00 of a 5 mc dose of 131J (preceded by thyrotrophin) was achieved. 
Opelration
The operation was carried out under general anaesthesia. A temporary tarsorrhaphy was done to protect the cornea. The antrum was approached as in a Caldwell-Luc operation, by an incision in the buccal mucosa over the anterior antral wall, the upper lip being retracted. The anterior bony wall of the antrum was removed and, working through the antrum, the ethmoids exenterated up to the orbital plate of the frontal bone. The bony medial wall and floor of the orbit were then removed, preserving the infra-orbital nerve. Four incisions were made, in a sagittal plane, in the orbital periosteum. Finally, an antrostomy was made in the antronasal wall, the buccal incision closed, and the tarsorrhaphy removed.
